Board of Trustees

Home  >>  BioRN Network  >>  Board of Trustees

The board of trustees is entrusted with the task of advising the executive board, in particular with regard to choosing project ideas and projects in biotechnology.

Prof. Dr. Mathias Hafner

(Chairman of the board of trustees)
Director of the Institute for Molecular- and Cell Biology, Mannheim University of Applied Sciences

Dr. Christof Antz

Luxendo GmbH

Dr. Juergen Bauer

Deputy Managing Director, Head of Business Development, EMBLEM Technology Transfer GmbH, Heidelberg

PD Dr. Gerard Drewes

Head of Science, Cellzome GmbH – a GSK company, Heidelberg

Prof. Dr. Alfred Hahn

Head of Discovery, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen

Prof. Dr. Klaus Heeg

Deputy speaker of the center of infection diseases,University Hospital Heidelberg

Dr. Thomas Höger

CEO / CFO, Apogenix GmbH

Dr. Susanne Arbogast

Head Innovation & External Affairs,
Roche Diagnostics GmbH, Penzberg

Dr. Thomas Pultar

Managing Director BIOMEVA GmbH, Heidelberg

Dr. Friedrich Rippmann

Director, Global Computational Chemistry
Merck KGaA, Darmstadt

Prof. Dr. Andreas Trumpp

Managing Director of HI-STEM
Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg